256 related articles for article (PubMed ID: 2164595)
1. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.
Holley-Guthrie EA; Quinlivan EB; Mar EC; Kenney S
J Virol; 1990 Aug; 64(8):3753-9. PubMed ID: 2164595
[TBL] [Abstract][Full Text] [Related]
2. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.
Quinlivan EB; Holley-Guthrie EA; Norris M; Gutsch D; Bachenheimer SL; Kenney SC
Nucleic Acids Res; 1993 Jul; 21(14):1999-2007. PubMed ID: 8393562
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor.
Zalani S; Holley-Guthrie EA; Gutsch DE; Kenney SC
J Virol; 1992 Dec; 66(12):7282-92. PubMed ID: 1331521
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
Sista ND; Pagano JS; Liao W; Kenney S
Proc Natl Acad Sci U S A; 1993 May; 90(9):3894-8. PubMed ID: 8387200
[TBL] [Abstract][Full Text] [Related]
5. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
J Virol; 2017 May; 91(9):. PubMed ID: 28228591
[TBL] [Abstract][Full Text] [Related]
6. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
Adamson AL; Kenney SC
Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214
[TBL] [Abstract][Full Text] [Related]
7. The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells.
Kenney SC; Holley-Guthrie E; Quinlivan EB; Gutsch D; Zhang Q; Bender T; Giot JF; Sergeant A
Mol Cell Biol; 1992 Jan; 12(1):136-46. PubMed ID: 1309587
[TBL] [Abstract][Full Text] [Related]
8. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
Zhang Q; Hong Y; Dorsky D; Holley-Guthrie E; Zalani S; Elshiekh NA; Kiehl A; Le T; Kenney S
J Virol; 1996 Aug; 70(8):5131-42. PubMed ID: 8764021
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.
Liu C; Sista ND; Pagano JS
J Virol; 1996 Apr; 70(4):2545-55. PubMed ID: 8642684
[TBL] [Abstract][Full Text] [Related]
10. Identification of an enhancer-type sequence that is responsive to Z and R trans-activators of Epstein-Barr virus.
Shimizu N; Sakuma S; Ono Y; Takada K
Virology; 1989 Oct; 172(2):655-8. PubMed ID: 2552665
[TBL] [Abstract][Full Text] [Related]
11. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.
Cox MA; Leahy J; Hardwick JM
J Virol; 1990 Jan; 64(1):313-21. PubMed ID: 2152819
[TBL] [Abstract][Full Text] [Related]
12. Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator.
Francis A; Ragoczy T; Gradoville L; Heston L; El-Guindy A; Endo Y; Miller G
J Virol; 1999 Jun; 73(6):4543-51. PubMed ID: 10233912
[TBL] [Abstract][Full Text] [Related]
13. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen.
Hardwick JM; Lieberman PM; Hayward SD
J Virol; 1988 Jul; 62(7):2274-84. PubMed ID: 2836611
[TBL] [Abstract][Full Text] [Related]
14. RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism.
Furnari FB; Zacny V; Quinlivan EB; Kenney S; Pagano JS
J Virol; 1994 Mar; 68(3):1827-36. PubMed ID: 8107245
[TBL] [Abstract][Full Text] [Related]
15. The bZip dimerization domain of the Epstein-Barr virus BZLF1 (Z) protein mediates lymphoid-specific negative regulation.
Hong Y; Holley-Guthrie E; Kenney S
Virology; 1997 Mar; 229(1):36-48. PubMed ID: 9123876
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein.
Nakayama S; Murata T; Murayama K; Yasui Y; Sato Y; Kudoh A; Iwahori S; Isomura H; Kanda T; Tsurumi T
J Biol Chem; 2009 Aug; 284(32):21557-68. PubMed ID: 19491105
[TBL] [Abstract][Full Text] [Related]
18. The Epstein-Barr virus (EBV) DNA polymerase accessory protein, BMRF1, activates the essential downstream component of the EBV oriLyt.
Zhang Q; Holley-Guthrie E; Ge JQ; Dorsky D; Kenney S
Virology; 1997 Mar; 230(1):22-34. PubMed ID: 9126259
[TBL] [Abstract][Full Text] [Related]
19. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
[TBL] [Abstract][Full Text] [Related]
20. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators.
Kenney S; Holley-Guthrie E; Mar EC; Smith M
J Virol; 1989 Sep; 63(9):3878-83. PubMed ID: 2548003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
